These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19776782)

  • 1. Lupus activation with cerebritis following pegylated interferon in a hemodialysis patient.
    Agarwal SK; Lal C; Zaidi SH
    Nat Rev Nephrol; 2009 Oct; 5(10):599-603. PubMed ID: 19776782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic lupus erythematosus syndrome induced by interferon therapy].
    Martínez Alfaro E; Mateos Rodríguez F; Blanch Sancho JJ; Tárraga Rodríguez I
    Med Clin (Barc); 2004 Oct; 123(15):597. PubMed ID: 15535949
    [No Abstract]   [Full Text] [Related]  

  • 3. Pegylated interferon alpha-2B induced lupus in a patient with chronic hepatitis B virus infection: case report.
    Yilmaz S; Cimen KA
    Clin Rheumatol; 2009 Oct; 28(10):1241-3. PubMed ID: 19653058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient.
    Pouthier D; Theissen F; Humbel RL
    Nephrol Dial Transplant; 2002 Jan; 17(1):174. PubMed ID: 11773492
    [No Abstract]   [Full Text] [Related]  

  • 5. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
    Alsaran K; Sabry A; Shaheen N
    Int Urol Nephrol; 2011 Sep; 43(3):865-73. PubMed ID: 20490669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare complication of pegylated interferon Alfa 2a in a hepatitis C-positive patient on maintenance hemodialysis.
    Satish R; ; Mathew T
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):139-42. PubMed ID: 22237239
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C.
    Ho V; Mclean A; Terry S
    J Clin Rheumatol; 2008 Jun; 14(3):166-8. PubMed ID: 18525437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-α induced lupus in a patient with chronic hepatitis C virus.
    Rizvi R; Hojjati M
    J Clin Rheumatol; 2011 Apr; 17(3):152-3. PubMed ID: 21441813
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
    Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
    Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection.
    Torres-Macho J; Jara-Chinarro B; Suárez-Aliaga B; Gámez-Díez S; García-de-Casasola G; de-Cuenca-Morón B
    Rev Esp Enferm Dig; 2010 Oct; 102(10):606-8. PubMed ID: 21039072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral nervous system involvement in a haemodialysis patient treated with pegylated interferon.
    Ruiz-Fuentes MC; Rubert-Gómez De Quero A; De Gracia-Guindo C; Galindo-Sacristán P; Osuna-Ortega A
    Nefrologia; 2012; 32(6):863-5. PubMed ID: 23169385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon alpha-2b induced lupus erythematosus in a patient with chronic hepatitis C infection].
    Muñoz-Rodríguez FJ; Andreu Solsona V; Tricas Leris JM; Vilaseca Bellsolà J
    Rev Clin Esp; 2002 May; 202(5):299-300. PubMed ID: 12060551
    [No Abstract]   [Full Text] [Related]  

  • 15. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
    Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
    Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
    Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
    Farshidi D; Chiu MW
    J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
    [No Abstract]   [Full Text] [Related]  

  • 18. Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
    Liu CH; Liang CC; Liu CJ; Lin JW; Chen SI; Hung PH; Tsai HB; Lai MY; Chen PJ; Chen DS; Kao JH
    Clin Infect Dis; 2010 Sep; 51(5):541-9. PubMed ID: 20645865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
    Potthoff A; Wiegand J; Lüth JB; Wedemeyer H; Manns MP; Tillmann HL
    Clin Nephrol; 2005 Mar; 63(3):232-5. PubMed ID: 15786827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyarthritis and anemia in a hemodialysis patient: systemic lupus erythematosus following treatment with interferon alpha.
    Touzot M; Touzot F; Galicier L; Ripault MP; Peraldi MN; Glotz D; Pillebout E
    Clin Nephrol; 2010 Apr; 73(4):318-20. PubMed ID: 20353741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.